{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:28:13Z","timestamp":1793118493464,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite major advances in the clinical management of non-small cell lung carcinoma (NSCLC), most patients treated with first-line platinum-based chemotherapy combined with immune checkpoint inhibitors will relapse, which constitutes an unmet medical need. Here, we found that various DNA damage inducers increase the levels of Notch Intracellular Domain (NICD), the active form of NOTCH1. Mechanistically, we revealed that, upon platinum treatment, the expression levels of both MDM2 and NICD were increased and that MDM2 stabilised NICD through ubiquitination. Using NSCLC patient-derived xenografts displaying intrinsic carboplatin resistance, we demonstrated that combining carboplatin with a \u03b3-secretase inhibitor, which hinders NICD generation, significantly improves survival and reduces tumour growth compared with carboplatin monotherapy. Furthermore, in patients with NSCLC who received platinum-based chemotherapy, the level of MDM2 expression in the tumour correlated with poor progression-free survival, which further validates the key role of MDM2 in response to platinum compounds. Our findings present a new therapeutic opportunity for patients with NSCLC, the most common form of lung cancer.<\/jats:p>","DOI":"10.1038\/s44321-025-00354-9","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:29:13Z","timestamp":1768559353000},"page":"514-541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinum"],"prefix":"10.1038","volume":"18","author":[{"given":"Sara","family":"Bernardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9516-9797","authenticated-orcid":false,"given":"Quentin Dominique","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bracquemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bouclier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Colomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maicol","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2744-3149","authenticated-orcid":false,"given":"Eric","family":"Fabbrizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4785-3567","authenticated-orcid":false,"given":"Sylvia-Fenosoa","family":"Rasamizafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina-Milissa","family":"Maacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Giry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Bousquet-Mur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Papon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Goussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Fremin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2581-433X","authenticated-orcid":false,"given":"Andrea","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3577-006X","authenticated-orcid":false,"given":"Mar\u00eda","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Travert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia K","family":"Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-0850","authenticated-orcid":false,"given":"Lisa","family":"Heron-Milhavet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6210-2713","authenticated-orcid":false,"given":"Alexandre","family":"Djiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-3364","authenticated-orcid":false,"given":"Luis","family":"Paz-Ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Quantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8739-1387","authenticated-orcid":false,"given":"Luis M","family":"Montuenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-8241","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Tourriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5527-5680","authenticated-orcid":false,"given":"Antonio","family":"Maraver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"354_CR1","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s12276-022-00863-4","volume":"54","author":"Y Abuetabh","year":"2022","unstructured":"Abuetabh Y, Wu HH, Chai C, Al Yousef H, Persad S, Sergi CM, Leng R (2022) DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities. Exp Mol Med 54:1658\u20131669","journal-title":"Exp Mol Med"},{"key":"354_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrg2268","volume":"9","author":"A Aguilera","year":"2008","unstructured":"Aguilera A, Gomez-Gonzalez B (2008) Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet 9:204\u2013217","journal-title":"Nat Rev Genet"},{"key":"354_CR3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.molcel.2018.01.023","volume":"69","author":"G Arena","year":"2018","unstructured":"Arena G, Cisse MY, Pyrdziak S, Chatre L, Riscal R, Fuentes M, Arnold JJ, Kastner M, Gayte L, Bertrand-Gaday C et al (2018) Mitochondrial MDM2 regulates respiratory complex I activity independently of p53. Mol Cell 69:594\u2013609.e598","journal-title":"Mol Cell"},{"key":"354_CR4","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1158\/0008-5472.CAN-08-3732","volume":"69","author":"A Bouska","year":"2009","unstructured":"Bouska A, Eischen CM (2009) Mdm2 affects genome stability independent of p53. Cancer Res 69:1697\u20131701","journal-title":"Cancer Res"},{"key":"354_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1172\/JCI126896","volume":"130","author":"E Bousquet Mur","year":"2020","unstructured":"Bousquet Mur E, Bernardo S, Papon L, Mancini M, Fabbrizio E, Goussard M, Ferrer I, Giry A, Quantin X, Pujol JL et al (2020) Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma. J Clin Invest 130:612\u2013624","journal-title":"J Clin Invest"},{"key":"354_CR6","doi-asserted-by":"publisher","first-page":"e48247","DOI":"10.15252\/embr.201948247","volume":"20","author":"KM Braunreiter","year":"2019","unstructured":"Braunreiter KM, Cole SE (2019) A tale of two clocks: phosphorylation of NICD by CDKs links cell cycle and segmentation clock. EMBO Rep 20:e48247","journal-title":"EMBO Rep"},{"key":"354_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrm.2016.94","volume":"17","author":"SJ Bray","year":"2016","unstructured":"Bray SJ (2016) Notch signalling in context. Nat Rev Mol Cell Biol 17:722\u2013735","journal-title":"Nat Rev Mol Cell Biol"},{"key":"354_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ceb.2017.12.008","volume":"51","author":"SJ Bray","year":"2018","unstructured":"Bray SJ, Gomez-Lamarca M (2018) Notch after cleavage. Curr Opin Cell Biol 51:103\u2013109","journal-title":"Curr Opin Cell Biol"},{"key":"354_CR9","doi-asserted-by":"publisher","first-page":"eaay2163","DOI":"10.1126\/scitranslmed.aay2163","volume":"12","author":"MY Cisse","year":"2020","unstructured":"Cisse MY, Pyrdziak S, Firmin N, Gayte L, Heuillet M, Bellvert F, Fuentes M, Delpech H, Riscal R, Arena G et al (2020) Targeting MDM2-dependent serine metabolism as a therapeutic strategy for liposarcoma. Sci Transl Med 12:eaay2163","journal-title":"Sci Transl Med"},{"key":"354_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.lungcan.2003.09.010","volume":"43","author":"D Dworakowska","year":"2004","unstructured":"Dworakowska D, Jassem E, Jassem J, Peters B, Dziadziuszko R, Zylicz M, Jakobkiewicz-Banecka J, Kobierska-Gulida G, Szymanowska A, Skokowski J et al (2004) MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC). Lung Cancer 43:285\u2013295","journal-title":"Lung Cancer"},{"key":"354_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05052-9","volume":"13","author":"F Ferrante","year":"2022","unstructured":"Ferrante F, Giaimo BD, Friedrich T, Sugino T, Mertens D, Kugler S, Gahr BM, Just S, Pan L, Bartkuhn M et al (2022) Hydroxylation of the NOTCH1 intracellular domain regulates Notch signaling dynamics. Cell Death Dis 13:600","journal-title":"Cell Death Dis"},{"key":"354_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13046-018-0871-7","volume":"37","author":"I Ferrer","year":"2018","unstructured":"Ferrer I, Quintanal-Villalonga A, Molina-Pinelo S, Garcia-Heredia JM, Perez M, Suarez R, Ponce-Aix S, Paz-Ares L, Carnero A (2018) MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma. J Exp Clin Cancer Res 37:195","journal-title":"J Exp Clin Cancer Res"},{"key":"354_CR13","doi-asserted-by":"publisher","first-page":"9889","DOI":"10.1021\/acs.jmedchem.8b01187","volume":"61","author":"KM Foote","year":"2018","unstructured":"Foote KM, Nissink JWM, McGuire T, Turner P, Guichard S, Yates JWT, Lau A, Blades K, Heathcote D, Odedra R et al (2018) Discovery and characterization of AZD6738, a potent inhibitor of ataxia telangiectasia mutated and Rad3 related (ATR) kinase with application as an anticancer agent. J Med Chem 61:9889\u20139907","journal-title":"J Med Chem"},{"key":"354_CR14","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodriguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF et al (2018) Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378:2078\u20132092","journal-title":"N Engl J Med"},{"key":"354_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccr.2012.04.011","volume":"21","author":"HS Gannon","year":"2012","unstructured":"Gannon HS, Woda BA, Jones SN (2012) ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice. Cancer Cell 21:668\u2013679","journal-title":"Cancer Cell"},{"key":"354_CR16","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s11864-022-01022-7","volume":"23","author":"N Girard","year":"2022","unstructured":"Girard N (2022) New strategies and novel combinations in EGFR TKI-resistant non-small cell lung cancer. Curr Treat Options Oncol 23:1626\u20131644","journal-title":"Curr Treat Options Oncol"},{"key":"354_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature09917","volume":"473","author":"V Guarani","year":"2011","unstructured":"Guarani V, Deflorian G, Franco CA, Kruger M, Phng LK, Bentley K, Toussaint L, Dequiedt F, Mostoslavsky R, Schmidt MHH et al (2011) Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 473:234\u2013238","journal-title":"Nature"},{"key":"354_CR18","doi-asserted-by":"publisher","first-page":"ra30","DOI":"10.1126\/scisignal.2005892","volume":"8","author":"K Hein","year":"2015","unstructured":"Hein K, Mittler G, Cizelsky W, Kuhl M, Ferrante F, Liefke R, Berger IM, Just S, Strang JE, Kestler HA et al (2015) Site-specific methylation of Notch1 controls the amplitude and duration of the Notch1 response. Sci Signal 8:ra30","journal-title":"Sci Signal"},{"key":"354_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.annonc.2022.12.013","volume":"34","author":"LE Hendriks","year":"2023","unstructured":"Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, Peters S, Planchard D, Smit EF, Solomon BJ et al (2023a) Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 34:358\u2013376","journal-title":"Ann Oncol"},{"key":"354_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","volume":"34","author":"LE Hendriks","year":"2023","unstructured":"Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, Peters S, Planchard D, Smit EF, Solomon BJ et al (2023b) Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 34:339\u2013357","journal-title":"Ann Oncol"},{"key":"354_CR21","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","volume":"21","author":"FR Hirsch","year":"2003","unstructured":"Hirsch FR, Varella-Garcia M, Bunn PA Jr, Di Maria MV, Veve R, Bremmes RM, Baron AE, Zeng C, Franklin WA (2003) Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 21:3798\u20133807","journal-title":"J Clin Oncol"},{"key":"354_CR22","doi-asserted-by":"publisher","first-page":"e0289619","DOI":"10.1371\/journal.pone.0289619","volume":"18","author":"K Hristova","year":"2023","unstructured":"Hristova K, Wimley WC (2023) Determining the statistical significance of the difference between arbitrary curves: a spreadsheet method. PLoS ONE 18:e0289619","journal-title":"PLoS ONE"},{"key":"354_CR23","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1038\/s41388-021-02055-2","volume":"40","author":"D Huang","year":"2021","unstructured":"Huang D, Savage SR, Calinawan AP, Lin C, Zhang B, Wang P, Starr TK, Birrer MJ, Paulovich AG (2021) A highly annotated database of genes associated with platinum resistance in cancer. Oncogene 40:6395\u20136405","journal-title":"Oncogene"},{"key":"354_CR24","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/cells10092222","volume":"10","author":"A Jevitt","year":"2021","unstructured":"Jevitt A, Huang YC, Zhang SM, Chatterjee D, Wang XF, Xie GQ, Deng WM (2021) Modeling Notch-induced tumor cell survival in the Drosophila ovary identifies cellular and transcriptional response to nuclear NICD accumulation. Cells 10:2222","journal-title":"Cells"},{"key":"354_CR25","doi-asserted-by":"publisher","first-page":"14973","DOI":"10.1073\/pnas.96.26.14973","volume":"96","author":"R Khosravi","year":"1999","unstructured":"Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D (1999) Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci USA 96:14973\u201314977","journal-title":"Proc Natl Acad Sci USA"},{"key":"354_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.molcel.2019.08.023","volume":"76","author":"L Krenning","year":"2019","unstructured":"Krenning L, van den Berg J, Medema RH (2019) Life or death after a break: what determines the choice?. Mol Cell 76:346\u2013358","journal-title":"Mol Cell"},{"key":"354_CR27","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1016\/S0960-9822(01)00679-0","volume":"12","author":"EC Lai","year":"2002","unstructured":"Lai EC (2002) Protein degradation: four E3s for the notch pathway. Curr Biol 12:R74\u2013R78","journal-title":"Curr Biol"},{"key":"354_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yexcr.2019.01.014","volume":"376","author":"S Li","year":"2019","unstructured":"Li S, Ren B, Shi Y, Gao H, Wang J, Xin Y, Huang B, Liao S, Yang Y, Xu Z et al (2019) Notch1 inhibition enhances DNA damage induced by cisplatin in cervical cancer. Exp Cell Res 376:27\u201338","journal-title":"Exp Cell Res"},{"key":"354_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2021.06.043","volume":"156","author":"YT Lin","year":"2021","unstructured":"Lin YT, Chiang CL, Hung JY, Lee MH, Su WC, Wu SY, Wei YF, Lee KY, Tseng YH, Su J et al (2021) Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a multicenter study using targeted next-generation sequencing. Eur J Cancer 156:1\u201311","journal-title":"Eur J Cancer"},{"key":"354_CR30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/0008-5472.CAN-12-1733","volume":"73","author":"YP Liu","year":"2013","unstructured":"Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J et al (2013) Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. Cancer Res 73:406\u2013416","journal-title":"Cancer Res"},{"key":"354_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ccr.2012.06.014","volume":"22","author":"A Maraver","year":"2012","unstructured":"Maraver A, Fernandez-Marcos PJ, Herranz D, Canamero M, Munoz-Martin M, Gomez-Lopez G, Mulero F, Megias D, Sanchez-Carbayo M, Shen J et al (2012) Therapeutic effect of gamma-secretase inhibition in Kras(G12V)-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK. Cancer Cell 22:222\u2013234","journal-title":"Cancer Cell"},{"key":"354_CR32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1101\/gad.886901","volume":"15","author":"R Maya","year":"2001","unstructured":"Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y et al (2001) ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev 15:1067\u20131077","journal-title":"Genes Dev"},{"key":"354_CR33","doi-asserted-by":"publisher","first-page":"E2939","DOI":"10.1073\/pnas.1206400109","volume":"109","author":"SM McAuliffe","year":"2012","unstructured":"McAuliffe SM, Morgan SL, Wyant GA, Tran LT, Muto KW, Chen YS, Chin KT, Partridge JC, Poole BB, Cheng KH et al (2012) Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci USA 109:E2939\u2013E2948","journal-title":"Proc Natl Acad Sci USA"},{"key":"354_CR34","doi-asserted-by":"publisher","first-page":"e608","DOI":"10.1002\/onco.13627","volume":"26","author":"TR McCaw","year":"2021","unstructured":"McCaw TR, Inga E, Chen H, Jaskula-Sztul R, Dudeja V, Bibb JA, Ren B, Rose JB (2021) Gamma secretase inhibitors in cancer: a current perspective on clinical performance. Oncologist 26:e608\u2013e621","journal-title":"Oncologist"},{"key":"354_CR35","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1101\/gad.1897010","volume":"24","author":"TG Oliver","year":"2010","unstructured":"Oliver TG, Mercer KL, Sayles LC, Burke JR, Mendus D, Lovejoy KS, Cheng MH, Subramanian A, Mu D, Powers S et al (2010) Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes Dev 24:837\u2013852","journal-title":"Genes Dev"},{"key":"354_CR36","unstructured":"Organization WH (2021) https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"354_CR37","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","volume":"379","author":"L Paz-Ares","year":"2018","unstructured":"Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gumus M, Mazieres J, Hermes B, Cay Senler F, Csoszi T, Fulop A et al (2018) Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med 379:2040\u20132051","journal-title":"N Engl J Med"},{"key":"354_CR38","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cell.2005.09.033","volume":"123","author":"MD Petroski","year":"2005","unstructured":"Petroski MD, Deshaies RJ (2005) Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34. Cell 123:1107\u20131120","journal-title":"Cell"},{"key":"354_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1042\/BJ20121249","volume":"450","author":"S Pettersson","year":"2013","unstructured":"Pettersson S, Sczaniecka M, McLaren L, Russell F, Gladstone K, Hupp T, Wallace M (2013) Non-degradative ubiquitination of the Notch1 receptor by the E3 ligase MDM2 activates the Notch signalling pathway. Biochem J 450:523\u2013536","journal-title":"Biochem J"},{"key":"354_CR40","doi-asserted-by":"publisher","first-page":"950","DOI":"10.15252\/emmm.201607265","volume":"9","author":"Y Ran","year":"2017","unstructured":"Ran Y, Hossain F, Pannuti A, Lessard CB, Ladd GZ, Jung JI, Minter LM, Osborne BA, Miele L, Golde TE (2017) gamma-secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct. EMBO Mol Med 9:950\u2013966","journal-title":"EMBO Mol Med"},{"key":"354_CR41","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.annonc.2021.06.001","volume":"32","author":"M Reck","year":"2021","unstructured":"Reck M, Carbone DP, Garassino M, Barlesi F (2021) Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches. Ann Oncol 32:1101\u20131110","journal-title":"Ann Oncol"},{"key":"354_CR42","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.molcel.2016.04.033","volume":"62","author":"R Riscal","year":"2016","unstructured":"Riscal R, Schrepfer E, Arena G, Cisse MY, Bellvert F, Heuillet M, Rambow F, Bonneil E, Sabourdy F, Vincent C et al (2016) Chromatin-bound MDM2 regulates serine metabolism and redox homeostasis independently of p53. Mol Cell 62:890\u2013902","journal-title":"Mol Cell"},{"key":"354_CR43","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","volume":"19","author":"F Skoulidis","year":"2019","unstructured":"Skoulidis F, Heymach JV (2019) Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy. Nat Rev Cancer 19:495\u2013509","journal-title":"Nat Rev Cancer"},{"key":"354_CR44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cub.2005.11.066","volume":"16","author":"VA Smits","year":"2006","unstructured":"Smits VA, Reaper PM, Jackson SP (2006) Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr Biol 16:150\u2013159","journal-title":"Curr Biol"},{"key":"354_CR45","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0092-8674(94)90502-9","volume":"78","author":"M Treier","year":"1994","unstructured":"Treier M, Staszewski LM, Bohmann D (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78:787\u2013798","journal-title":"Cell"},{"key":"354_CR46","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1182\/blood-2008-04-152710","volume":"112","author":"CS Tremblay","year":"2008","unstructured":"Tremblay CS, Huang FF, Habi O, Huard CC, Godin C, Levesque G, Carreau M (2008) HES1 is a novel interactor of the Fanconi anemia core complex. Blood 112:2062\u20132070","journal-title":"Blood"},{"key":"354_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nsmb.3013","volume":"22","author":"J Vermezovic","year":"2015","unstructured":"Vermezovic J, Adamowicz M, Santarpia L, Rustighi A, Forcato M, Lucano C, Massimiliano L, Costanzo V, Bicciato S, Del Sal G et al (2015) Notch is a direct negative regulator of the DNA-damage response. Nat Struct Mol Biol 22:417\u2013424","journal-title":"Nat Struct Mol Biol"},{"key":"354_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6086","volume":"5","author":"W Wang","year":"2014","unstructured":"Wang W, Qin JJ, Voruganti S, Srivenugopal KS, Nag S, Patil S, Sharma H, Wang MH, Wang H, Buolamwini JK et al (2014) The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models. Nat Commun 5:5086","journal-title":"Nat Commun"},{"key":"354_CR49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/B978-0-12-405943-6.00008-7","volume":"110","author":"D Weber","year":"2014","unstructured":"Weber D, Wiese C, Gessler M (2014) Hey bHLH transcription factors. Curr Top Dev Biol 110:285\u2013315","journal-title":"Curr Top Dev Biol"},{"key":"354_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc2290","volume":"8","author":"M Welcker","year":"2008","unstructured":"Welcker M, Clurman BE (2008) FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8:83\u201393","journal-title":"Nat Rev Cancer"},{"key":"354_CR51","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.molcel.2012.08.022","volume":"48","author":"A Yatim","year":"2012","unstructured":"Yatim A, Benne C, Sobhian B, Laurent-Chabalier S, Deas O, Judde JG, Lelievre JD, Levy Y, Benkirane M (2012) NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol Cell 48:445\u2013458","journal-title":"Mol Cell"},{"key":"354_CR52","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2017.11.009","volume":"818","author":"H Zhang","year":"2018","unstructured":"Zhang H, Jiang H, Chen L, Liu J, Hu X, Zhang H (2018) Inhibition of Notch1\/Hes1 signaling pathway improves radiosensitivity of colorectal cancer cells. Eur J Pharm 818:364\u2013370","journal-title":"Eur J Pharm"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00354-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00354-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00354-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:45:24Z","timestamp":1779065124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00354-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,13]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00354-9","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}